Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the long term safety and tolerability of multiple
oral doses of tipranavir (Aptivus) and ritonavir with a focus on the long term safety of the
development dose (500 mg tipranavir/200 mg ritonavir BID) when administered with other
antiretroviral medications.